Cases 11 - 20 of 438
IVERS v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv21150
Plaintiff:
ANTHONY IVERS
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., ARROW PHARM (MALTA) LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Louisiana Health Service & Indemnity Company et al v. Celgene Corporation et al
as 1:2023cv07871
Plaintiff:
Louisiana Health Service & Indemnity Company individually and on behalf of all others similarly situated doing business as Blue Cross and Blue Shield of Louisiana and HMO Louisiana, Inc.
Defendant:
Celgene Corporation, Bristol Myers Squibb Company, Aurobindo Pharma Limited and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation (Monopolizing Trade)
ANDERSON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv13680
Plaintiff:
JERRY ANDERSON and PHILISA J. ANDERSON
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
KENNEDY v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv13282
Plaintiff:
ROBERT KENNEDY
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WOJNICKI v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04496
Plaintiff:
JAMES WOJNICKI
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
SHANNON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04229
Plaintiff:
STANLEY SHANNON and NELLIE F. LAWLER-SHANNON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WORTHEN et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04163
Plaintiff:
GARY L. WORTHEN and LOLA E. WORTHEN
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HILL et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04125
Plaintiff:
REGINA HILL and BARRY HILL
Defendant:
AUROBINDO PHARMA, LTD., AUROLIFE PHARMA, LLC, AUROBINDO PHARMA USA, INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WILLIAMS v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03909
Plaintiff:
KENNETH W. WILLIAMS
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
ABDELMALLEK v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03842
Plaintiff:
Hany Abdelmallek
Defendant:
AUROBINDO PHARMA, LTD., ARROW PHARM (MALTA) LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
